With the CDN pushing against 30 year highs I decided to increase my position in JNJ. I’ve posted these reasons before but here they are again:
-44 years of consistent dividend growth.
-Dividends issued to shareowners every quarter since 1944.
-Dividend raised each year for 44 consecutive years.
-Sales have increased each year for 73 consecutive years.
-Double digit Earnings increases for 21 consecutive years.
-Current yield of 2.50%
-44% of sales outside of North America
-ROE levels of above 21% for the past 10 years
-Current P/E – 16.18
-Projected 2007 P/E – 15.3
-Projected 2008 P/E – 13.44
-4 Star rating from S&P - $74 one year target
-Argus rates it a buy with a $76 one year target
I like their diversified holdings within the healthcare sector particularly their consumer products.
(Disclaimer: I’m not your boss or your spouse so do you own research and make your opinions on when to buy or sell. Nothing I say should be bastardized or construed in any way to be advice)
skip to main |
skip to sidebar
Subscribe:
Blog Archive
-
▼
2007
(161)
-
▼
May
(18)
- Trillion Dollar Charge - Inflation= High Postal Fees?
- High Yield Bond Risk
- Hybrid Vehicle Rebates
- Canadian vs. US Dollar
- JNJ (again)
- Stock Splits
- Garage Sale Follow Up & Lessons Learned
- GO.A – Galleon Energy
- Don’t Retire Early? – My View on the Subject
- Don’t Retire Early?
- Pay Down the Mortgage or Invest?
- Useless Junk = Garage Sale
- Dividend Growing Stocks – III
- Questrade - Review
- ZED
- Compensation of Financial Advisors – A Middle Clas...
- Canadian Tour of Personal Finance Blogs
- Retirement Nest Egg May 1 - 2007
-
▼
May
(18)
Learn about Finance
& Economics
degrees from Walden
University, Capella
University, and Baker
College |
Sponsors
instant check cash advance from the company that participate in the program offered by Better Business Bureau.Apply for quick cash advance from a leading payday lending company.
Now there is new and most secure way for global money transfer . Make an online transfer to friends and family using visa prepaid card.
Now there is new and most secure way for global money transfer . Make an online transfer to friends and family using visa prepaid card.
Resources & Tools
Search
Email Me:
Blogs I Read
- 2million
- Canadian Capitalist
- Canadian Dream Free at 45
- Canadian Financial Stuff
- Dividends 4 Life
- Ellen Roseman
- Financial Jungle
- Four Pillars
- Larry MacDonald
- Million Dollar Journey
- The Dividend Guy Blog
- The Financial Blogger
- The Money Gardener
- Thicken my Wallet
- Triaging my Way to Financial Success
- Wall Street Fighter
Middle Class Millionaire
7 comments:
These P/E levels are historically low. I caught Jim Cramer last night basically saying that JNJ is a dog and will finish the year at $63. I don't agree.
This is a phenomenal company that tends to be underestimated in the market. They are so consistent that I would be quite please with 7-8% growth plus the dividend each year, knowing that I bought in when they were trading a historically low levels.
I would tend to agree with you. Although Jim Cramer is obviously a successful trader his style is dramatically different than mine and yours. He takes a “go big or go home” kind of approach and his recommendations change from month to month based on the latest quarter, whereas I tend to buy on a weaker quarter. I think we are more long term investors. I don’t plan on selling JNJ ever...and will be happy with an 8-15% annual share price appreciation plus a 5 to 10% annual increase in the dividend. Jim Cramer may have a $63 target but S&P has a $74 target and Argus has a $76 target. I guess time will tell.
Agreed. I wouldn't care much if the stock finished the year at $63 anyway. I won't be selling this one anytime over the next 15 years.
MCM, I've been eyeing JNJ for a little while now too. Are you buying it in a non-registered account? I understand that foreign dividends get taxed like regular income in non-registered accounts. Is there any way around this or any effective strategies to reduce the tax? I'm curious to know if you have thought about this.
Good pick. I am not a big believer in target prices but JNJ is a fundamentally sound company with retail products off-setting any slump in their pharma pipeline.
With respect to the tax issue, you also have to look at with-holding taxes on dividends paid by non Cdn. companies.
maxroi,
I own some in an RSP and some in a non-sheltered account.
thicken,
good point about the 15% withholding tax
J&J is one excellent company.
Post a Comment